20.50
price down icon0.05%   -0.01
 
loading
Pharvaris Nv stock is traded at $20.50, with a volume of 51,688. It is down -0.05% in the last 24 hours and down -3.30% over the past month. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .
See More
Previous Close:
$20.51
Open:
$20.36
24h Volume:
51,688
Relative Volume:
0.55
Market Cap:
$1.11B
Revenue:
-
Net Income/Loss:
$-123.41M
P/E Ratio:
-9.5884
EPS:
-2.138
Net Cash Flow:
$-106.93M
1W Performance:
+2.30%
1M Performance:
-3.30%
6M Performance:
-0.77%
1Y Performance:
+34.87%
1-Day Range:
Value
$18.81
$20.55
1-Week Range:
Value
$18.81
$21.85
52-Week Range:
Value
$15.00
$33.00

Pharvaris Nv Stock (PHVS) Company Profile

Name
Name
Pharvaris Nv
Name
Phone
-
Name
Address
-
Name
Employee
82
Name
Twitter
Name
Next Earnings Date
2024-08-05
Name
Latest SEC Filings
Name
PHVS's Discussions on Twitter

Compare PHVS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PHVS 20.50 1.11B 0 -123.41M -106.93M -2.138
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-25-23 Initiated Wedbush Outperform
Aug-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-05-22 Initiated Bryan Garnier Buy
Sep-13-22 Resumed JMP Securities Mkt Outperform
Aug-23-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-22-22 Downgrade BofA Securities Neutral → Underperform
May-25-22 Initiated JMP Securities Mkt Outperform
Mar-02-21 Initiated BofA Securities Neutral
Mar-02-21 Initiated Morgan Stanley Overweight
Mar-02-21 Initiated Oppenheimer Outperform
Mar-02-21 Initiated SVB Leerink Outperform
View All

Pharvaris Nv Stock (PHVS) Latest News

pulisher
Nov 14, 2024

(PHVS) Long Term Investment Analysis - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 13, 2024

Pharvaris Reports 93% HAE Attack Reduction in Trial Data, Plans Phase 3 Study | PHVS Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Pharvaris to Present HAE Treatment Progress at Guggenheim Healthcare Conference | PHVS Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 03, 2024

Trend Tracker for (PHVS) - Stock Traders Daily

Nov 03, 2024
pulisher
Oct 30, 2024

Axonis Therapeutics Announces $115 Million Series A Financing - Financial Times

Oct 30, 2024
pulisher
Oct 24, 2024

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

(PHVS) Proactive Strategies - Stock Traders Daily

Oct 23, 2024
pulisher
Oct 16, 2024

Pharvaris (PHVS) Shares Cross Above 200 DMA - Nasdaq

Oct 16, 2024
pulisher
Oct 16, 2024

PHVSPharvaris N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Oct 16, 2024
pulisher
Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at ... - The Hastings Tribune

Oct 16, 2024
pulisher
Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings - StockTitan

Oct 16, 2024
pulisher
Oct 15, 2024

Pharvaris to Host Virtual Investor Event on October 23, 2024 - StockTitan

Oct 15, 2024
pulisher
Oct 13, 2024

(PHVS) Investment Report - Stock Traders Daily

Oct 13, 2024
pulisher
Oct 09, 2024

Pharvaris (NASDAQ:PHVS) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Oct 09, 2024
pulisher
Oct 04, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap DownShould You Sell? - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at - The Bakersfield Californian

Oct 03, 2024
pulisher
Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop - StockTitan

Oct 03, 2024
pulisher
Sep 30, 2024

Novo Holdings A S Buys 556,970 Shares of Pharvaris (NASDAQ:PHVS) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Pharvaris N.V.'s SWOT analysis: promising HAE drug boosts stock outlook - Investing.com India

Sep 30, 2024
pulisher
Sep 25, 2024

Pharvaris CBO Resigns, Team Absorbs Duties - TipRanks

Sep 25, 2024
pulisher
Sep 21, 2024

(PHVS) Technical Data - Stock Traders Daily

Sep 21, 2024
pulisher
Sep 20, 2024

Hereditary Angioedema Therapeutics Global Market Report Explores 2024: Size Forecast and Growth Prospects 2033 - WhaTech

Sep 20, 2024
pulisher
Sep 20, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap Down to $21.09 - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma - sharewise

Sep 20, 2024
pulisher
Sep 19, 2024

Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Sep 19, 2024
pulisher
Sep 19, 2024

Paradise, NV – Injuries Reported in Vehicle Accident on I-215 W near Las Vegas Blvd Onramp - Local Accident Reports

Sep 19, 2024
pulisher
Sep 18, 2024

Las Vegas, NV – Accident on I-215 E near Windmill Ln Results in Injuries - Local Accident Reports

Sep 18, 2024
pulisher
Sep 18, 2024

North Las Vegas Man Charged in Fatal Hit-and-Run After Allegedly Fleeing Accident Scene - Hoodline

Sep 18, 2024
pulisher
Sep 17, 2024

Paradise, NV – Vehicle Accident at I-215 E and Las Vegas Blvd - Local Accident Reports

Sep 17, 2024
pulisher
Sep 17, 2024

Las Vegas, NV – Vehicle Accident at CC215 S and W Sunset Rd Causes Injuries - Local Accident Reports

Sep 17, 2024
pulisher
Sep 17, 2024

Highway reopens outside Las Vegas after crash, fire in semi hauling lithium batteries - KRNV

Sep 17, 2024
pulisher
Sep 17, 2024

Road closures persist after trucks carrying wood and batteries collide - News3LV

Sep 17, 2024
pulisher
Sep 17, 2024

Appeal over identifying invasive hornets in Jersey - BBC.com

Sep 17, 2024
pulisher
Sep 17, 2024

Hwy 95 closes in Nye County after crash involving truck carrying lithium batteries - Audacy

Sep 17, 2024
pulisher
Sep 16, 2024

1 person transported to hospital after Henderson crash involving bicyclist - Fox 5 Las Vegas

Sep 16, 2024
pulisher
Sep 16, 2024

1 hospitalized in Henderson crash involving bicyclistKLAS - KLAS - 8 News Now

Sep 16, 2024
pulisher
Sep 16, 2024

Oregon man dies northwest of Las Vegas Valley, state police say - Fox 5 Las Vegas

Sep 16, 2024
pulisher
Sep 16, 2024

1 person taken to hospital after crash involving car, bicyclist in Henderson - News3LV

Sep 16, 2024
pulisher
Sep 16, 2024

Rep. Steven Horsford releases updated campaign ad after LVPPA concerns - KTNV 13 Action News Las Vegas

Sep 16, 2024
pulisher
Sep 16, 2024

Silver Springs man killed in crash on U.S. 50A & 6th Street in Fernley - KTVN

Sep 16, 2024
pulisher
Sep 12, 2024

Las Vegas, NV – Collision at CC215 S & W Flamingo Rd Results in Injuries - Local Accident Reports

Sep 12, 2024
pulisher
Sep 06, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap Up After Analyst Upgrade - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Pharvaris stock outlook strengthened with price target increase, Outperform rating reiterated by Oppenheimer - Investing.com UK

Sep 06, 2024
pulisher
Sep 06, 2024

(PHVS) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 06, 2024
pulisher
Sep 05, 2024

Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and ... - The Bakersfield Californian

Sep 05, 2024
pulisher
Sep 05, 2024

Pharvaris Provides Business Update and Expands Development Program for Deucrictibant - StockTitan

Sep 05, 2024
pulisher
Sep 05, 2024

Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 - StockTitan

Sep 05, 2024
pulisher
Sep 05, 2024

Pharvaris Presents Data at the Bradykinin Symposium 2024 - StockTitan

Sep 05, 2024
pulisher
Sep 04, 2024

Pharvaris to Present at SVB Securities Global Biopharma Conference - Yahoo Finance UK

Sep 04, 2024
pulisher
Aug 28, 2024

Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium - Yahoo Finance UK

Aug 28, 2024
pulisher
Aug 27, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap Down to $19.08 - MarketBeat

Aug 27, 2024

Pharvaris Nv Stock (PHVS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):